Home › Funds › Nantahala Capital Management, LLC › SLN
Nantahala Capital Management, LLC position in SLN
SILENCE THERAPEUTICS PLC · Health Care
Nantahala Capital Management, LLC reported holding 1,346,731 shares of SLN (SILENCE THERAPEUTICS PLC) in its Q2 2026 13F filing — a position valued at US$14.8M, representing 0.59% of its reported portfolio and ranking #45 among its reported holdings. Nantahala Capital Management, LLC has disclosed SLN holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Nantahala Capital Management, LLC's SLN position evolved
Nantahala Capital Management, LLC first disclosed a stake in SLN in Q1 2024 at 200,000 shares (US$4.3M). The position peaked in Q2 2026 at 1,346,731 shares, worth US$14.8M. Across 10 filings, Nantahala Capital Management, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 1,346,731 shares valued at US$14.8M — a reduction of -800,000 shares quarter over quarter.. Notable position changes include a 425% increase in Q4 2024 (shares fell 59% over the following quarter), a 48% increase in Q4 2025 (shares fell 13% over the following quarter), a 39% increase in Q1 2026 (shares rose 108% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 200.00K | $4.32M | New |
| Q2 2024 | 200.00K | $3.80M | Hold |
| Q3 2024 | 200.00K | $3.64M | Hold |
| Q4 2024 | 1.05M | $7.22M | Add |
| Q1 2025 | 1.04M | $2.94M | Reduce |
| Q2 2025 | 1.04M | $6.05M | Hold |
| Q3 2025 | 1.04M | $5.41M | Hold |
| Q4 2025 | 1.54M | $9.38M | Add |
| Q1 2026 | 2.15M | $11.31M | Add |
| Q2 2026 | 1.35M | $14.79M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SLN and 13F data
SLN (SILENCE THERAPEUTICS PLC) is a Health Care company. 35 other funds we track also report a position in SLN — the largest reported positions include Siren, L.L.C. (US$36.4M), TCG Crossover Management, LLC (US$33.3M), Redmile Group, LLC (US$23.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SLN
- Siren, L.L.C. 3.31M sh · $36.36M · Q2 2026
- TCG Crossover Management, LLC 3.03M sh · $33.31M · Q2 2026
- Redmile Group, LLC 2.16M sh · $23.77M · Q2 2026
- Nextech Invest Ltd. 952.40K sh · $10.46M · Q2 2026
- 5AM Venture Management, LLC 476.20K sh · $5.23M · Q2 2026
- GREAT POINT PARTNERS LLC 450.00K sh · $4.94M · Q2 2026
- Tetragon Partners GP Ltd 300.00K sh · $3.29M · Q2 2026
- Ishara Investments LP 55.35K sh · $2.43M · Q2 2026
- Propel Bio Management, LLC 191.73K sh · $2.11M · Q2 2026
- M28 Capital Management LP 101.20K sh · $1.11M · Q2 2026
More on Nantahala Capital Management, LLC
FAQ
How long has Nantahala Capital Management, LLC held SLN?
Nantahala Capital Management, LLC has disclosed SLN holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is Nantahala Capital Management, LLC's current position in SLN?
As of Q2 2026, Nantahala Capital Management, LLC holds 1.35M shares of SLN (SILENCE THERAPEUTICS PLC), valued at $14.79M, representing 0.59% of its reported portfolio and ranking #45.
Has Nantahala Capital Management, LLC been buying or selling SLN?
In the latest 13F filing (Q2 2026), Nantahala Capital Management, LLC reduced its position in SLN. The position peaked in Q2 2026 at 1.35M shares.
Which other funds hold SLN?
Other major institutional holders of SLN include Siren, L.L.C., TCG Crossover Management, LLC, Redmile Group, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.